PolyPid Announces Positive Top-line Results from Phase 2 Clinical Trial of D-PLEX100 for the Prevention of Surgical Site Infections in Abdominal Surgery

NEXT STORY
Safety and Antiviral Activity of Assembly Biosciences’ First and Second Generation Core Inhibitor Candidates In the Treatment of Chronic Hepatitis B to be Featured in a Late Breaking Session at AASLD
PREV STORY
Roche reports very strong sales growth in the first nine months of 2019 – outlook raised
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Lancets Market to grow at 12.0% CAGR to hit US $1,695.8 million by 2025– Global Insights on Trends, Share Analysis, Leading Players, Key Stakeholders, Business Opportunities and Future Prospect: Adroit Market Research

author_avatar
NASDAQ Market News

Motus GI Announces Publication of Pure-Vu® System Clinical Data in Peer-Reviewed Journal BMC Gastroenterology

author_avatar
NASDAQ Market News

Data from New Analyses of Studies with Veltassa® Presented at 53rd European Renal Association Congress

REDWOOD CITY, Calif., May 22, 2016 (GLOBE NEWSWIRE) -- Relypsa, Inc. (NASDAQ:RLYP), a biopharmaceutical ...

author_avatar
NASDAQ Market News